Quarterly Transactions Made in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). The information is specifically focused on institutions that hold shares of Aclaris Therapeutics, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 4,926,423 | 1,994,726 | 6,921,149 | 4,309,381 | 1,394,200 | 5,703,581 | 1,217,568 | |
Q4 2021 | 3,947,515 | 1,676,081 | 5,623,596 | 2,793,310 | 3,635,820 | 6,429,130 | -805,534 | |
Q1 2022 | 6,982,962 | 2,865,109 | 9,848,071 | 4,229,160 | 2,111,650 | 6,340,810 | 3,507,261 | |
Q2 2022 | 6,658,511 | 812,102 | 7,470,613 | 2,987,115 | 400,811 | 3,387,926 | 4,082,687 | |
Q3 2022 | 1,958,618 | 687,192 | 2,645,810 | 2,312,741 | 68,000 | 2,380,741 | 265,069 | |
Q4 2022 | 3,203,773 | 2,854,053 | 6,057,826 | 3,280,388 | 42,528 | 3,322,916 | 2,734,910 | |
Q1 2023 | 7,807,680 | 10,467,014 | 18,274,694 | 8,269,079 | 0 | 8,269,079 | 10,005,615 | |
Q2 2023 | 5,685,448 | 2,127,995 | 7,813,443 | 2,940,377 | 0 | 2,940,377 | 4,873,066 | |
Q3 2023 | 7,860,914 | 934,073 | 8,794,987 | 4,869,990 | 0 | 4,869,990 | 3,924,997 | |
Q4 2023 | 17,491,058 | 10,422,572 | 27,913,630 | 4,116,989 | 0 | 4,116,989 | 23,796,641 | |
Q1 2024 | 11,344,840 | 2,214,386 | 13,559,226 | 11,119,456 | 0 | 11,119,456 | 2,439,770 | |
Q2 2024 | 4,668,333 | 5,755,951 | 10,424,284 | 11,250,222 | 100 | 11,250,322 | -826,038 | |
Q3 2024 | 3,484,222 | 1,262,363 | 4,746,585 | 3,658,948 | 22,524 | 3,681,472 | 1,065,113 |